PIK3CA and adenocarcinoma: Study through NGS restricted gene panels showed that incidence of K- and N-RAS, PIK3CA, APC, and TP53 mutations are lower compared to adenocarcinoma suggesting that alternate pathways may be involved in SRCC tumorigenesis [82].